Industry Experts

Venita De Almeida is a seasoned biopharmaceutical professional with extensive experience in oncology drug development, including ADCs, bispecifics, fusion proteins, and antibodies. She has led programs from early discovery through IND and clinical development, with a focus on translational research and strategic planning.

Venita began her career at Northwestern University and completed her postdoctoral fellowship at Genentech, where she contributed to biologics targeting the Wnt signaling pathway and multiple ADC programs. She went on to lead preclinical and clinical development efforts at Sutro Biopharma, 3T Biosciences, ALX Oncology, and Nexoplex Bio playing a key role in advancing novel biologics into the clinic.